Lupin Limited has informed the Exchange about press release dated 04-Nov-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Drospirenone Tablets.
Press Release Nov 04 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Oct 20 2022
- Press Release Oct 07 2022
- Press Release Oct 06 2022
- Press Release Oct 04 2022
- Press Release Oct 01 2022
Later from Lupin
- Press Release Nov 08 2022
- Press Release Nov 09 2022
- Press Release Nov 21 2022
- Press Release Nov 28 2022
- Press Release Nov 29 2022
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin